Jrnl-Pharmaceutical Sciences is categorized under Data Base Information Retrieval in Hoboken, NJ .
Jrnl-Pharmaceutical Sciences was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Data Base Information Retrieval business, which does work in the B2B market, and is classified as a Data Base Information Retrieval, under code number 5111200 by the NAICS.
If you are seeking more information, feel free to contact Bill Stein at the company’s branch by writing to 111 River St, Hoboken, New Jersey NJ 07030 or by phoning (201) 748-6000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jrnl-Pharmaceutical Sciences |
| Contact Person: | Bill Stein |
| Address: | 111 River St, Hoboken, New Jersey 07030 |
| Phone Number: | (201) 748-6000 |
| Website Address: | wiley.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Data Base Information Retrieval |
| SIC Code: | 7375 |
| NAICS Code: | 5111200 |
| Share This Business: |
Jrnl-Pharmaceutical Sciences was started in 0 to provide professional Data Base Information Retrieval under the SIC code 7375 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bill Stein for inquiries that concern Jrnl-Pharmaceutical Sciences by calling the company number (201) 748-6000, as your correspondence is most welcome. Additionally, the physical location of the branch of Jrnl-Pharmaceutical Sciences can be found at the coordinates 40.737232,-74.028714 as well as the street address 111 River St in Hoboken, New Jersey 07030.
For its online presence, you may visit Jrnl-Pharmaceutical Sciences’s website at wiley.com and engage with its social media outlets through on Twitter and on Facebook.